December 2007

GlaxoSmithKline’s Hamilton, MT manufacturing plant expansion had its grand opening on October 18, 2007. The $137 million, 130,000-square-foot facility produces the MPL adjuvant as part of the research and production of a vaccine for human papillomavirus called Cervarix. More than 130 new positions have been filled at the facility so far this year.

[button url=”” target=”_blank” size=”small” style=”limegreen” ]View Newsletter[/button]